作者
Kevin P Hill, Mark S Gold, Charles B Nemeroff, William McDonald, Adrienne Grzenda, Alik S Widge, Carolyn Rodriguez, Nina V Kraguljac, John H Krystal, Linda L Carpenter
发表日期
2022/2
来源
American Journal of Psychiatry
卷号
179
期号
2
页码范围
98-109
出版商
American Psychiatric Association
简介
Objective
The United States is in the midst of rapidly changing laws regarding cannabis. The increasing availability of cannabis for recreational and medical use requires that mental health clinicians be knowledgeable about evidence to be considered when counseling both patients and colleagues. In this review, the authors outline the evidence from randomized double-blind placebo-controlled trials for therapeutic use of cannabinoids for specific medical conditions and the potential side effects associated with acute and chronic cannabis use.
Methods
Searches of PubMed and PsycInfo were conducted for articles published through July 2021 reporting on “cannabis” or “cannabinoids” or “medicinal cannabis.” Additional articles were identified from the reference lists of published reviews. Articles that did not contain the terms “clinical trial” or “therapy” in the title or abstract were not reviewed. A total of 4,431 articles …
引用总数
学术搜索中的文章
KP Hill, MS Gold, CB Nemeroff, W McDonald… - American Journal of Psychiatry, 2022